articleBMJMay 13, 2010HYBRID OA

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Academic Medical Center · Ziekenhuis Bethesda · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Objectives

To study the effects of metformin on the incidence of vitamin B-12 deficiency (220 pmol/l).

Conclusions

Long term treatment with metformin increases the risk of vitamin B-12 deficiency, which results in raised homocysteine concentrations. Vitamin B-12 deficiency is preventable; therefore, our findings suggest that regular measurement of vitamin B-12 concentrations during long term metformin treatment should be strongly considered. Trial registration Clinicaltrials.gov NCT00375388.

Citation impact

680
total citations
FWCI
28.93
Percentile
100%
References
35
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Metformin
  • Placebo
  • Internal medicine
  • Type 2 diabetes
  • Homocysteine
  • Confidence interval
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.